We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Applied Biosystems and Eppendorf Announce Licensing Agreement
News

Applied Biosystems and Eppendorf Announce Licensing Agreement

Applied Biosystems and Eppendorf Announce Licensing Agreement
News

Applied Biosystems and Eppendorf Announce Licensing Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Applied Biosystems and Eppendorf Announce Licensing Agreement "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Applied Biosystems Group, an Applera Corporation business, has announced it has granted a worldwide, royalty-bearing license to Eppendorf AG under a real-time thermal cycler patent rights agreement.

Under the agreement, Eppendorf will have the right to manufacture and sell real-time thermal cyclers in the research and applied fields.

"This agreement with Eppendorf further validates the significance of Applied Biosystems' real-time thermal cycler technology," said Paul D. Grossman, Ph.D., Esq., Vice President, Strategic Planning, Business Development and Intellectual Property for Applied Biosystems.

"We may consider entering into additional licenses with high quality vendors under the right terms."

"We are pleased to announce our agreement with Applied Biosystems," said Klaus Fink, CEO and President of Eppendorf AG.

"We are committed to providing our customers with access to technologies that are of greatest importance for the life sciences sector."

"Our new product generation of real-time cyclers ensures best practices in laboratories in terms of productivity, simplicity, and ease of use."

The license to Eppendorf is based on U.S. Patent No. 6,814,934 and foreign equivalents.

The U.S. Patent & Trademark Office (USPTO) granted Applera this fundamental patent pertaining to real-time PCR instrumentation in November 2004.

Advertisement